Search Results - N. G. Kashevarova

Refine Results
  1. 1

    RISK FACTORS OF THE KNEE OSTEOARTHRITIS PROGRESSION by N. G. Kashevarova, L. I. Alekseeva

    Published 2014-10-01

    The present review is devoted to the problem of progression of the knee osteoarthritis. It has been shown that the most important predictors of the disease progression are female gender, strong knee pain, synovitis,deformation of joints, high body mass index, previous traumas, high bone mineral dens...

    Full description

    Get full text
    Article
  2. 2

    Efficacy of intra-articular of high molecular weight hyaluronic acid injections in in osteoarthritis of the knee and hip by L. I. Alekseeva, N. G. Kashevarova

    Published 2021-09-01

    The presence of pain syndrome and an increase in functional insufficiency of the joints are the most frequent reasons for patients seeking medical help. Currently, given the growing prevalence of osteoarthritis, a more active multimodal approach to patient management is needed, taking into account t...

    Full description

    Get full text
    Article
  3. 3

    Osteoarthritis: epidemiology, classification, risk factors, and progression, clinical presentation, diagnosis, and treatment by L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova

    Published 2019-05-01

    For the first time, the paper presents in detail the prevalence of osteoarthritis (OA) and considers the predictors of disease development and progression. The clinical classification of OA and its place in the ICD-10 are described. The clinical presentation of the disease is characterized in detail...

    Full description

    Get full text
    Article
  4. 4

    FUNCTIONS OF THE mTOR SIGNALING PATHWAY IN NORMAL ARTICULAR CARTILAGE CHONDROCYTES AND IN OSTEOARTHRITIS by E. V. Chetina, N. G. Kashevarova, E. P. Sharapova

    Published 2016-12-01

    Osteoarthritis  (OA) is a chronic disease associated with pain, stiffness, limited mobility and joint inflammation, as well as articular cartilage destruction.  Recent studies have shown the importance  of chondrocyte  differentiation (hypertrophy) as one of the mechanisms  of cartilage degradation...

    Full description

    Get full text
    Article
  5. 5

    The place of nonsteroidal anti-inflammatory drugs in the current osteoarthritis guidelines by E. A. Taskina, N. G. Kashevarova, L. I. Alekseeva

    Published 2020-05-01

    The paper provides a review of the data available in the literature on the relationship of pain to the risk of OA progression. Network analyses and numerous studies, including those conducted at the V.A. Nasonova Research Institute of Rheumatology, have confirmed that pain syndrome is one of the sig...

    Full description

    Get full text
    Article
  6. 6

    Symptomatic delayed-acting drugs (SYSADOA): new applications by A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova

    Published 2022-05-01

    The review systematizes modern data indicating effective pain control and a significant improvement in the functional activity of patients suffering from osteoarthritis (OA) using pharmaceutical substances of chondroitin sulfate (CS) and glucosamine (GA). The effect of a combination of CS and GA on...

    Full description

    Get full text
    Article
  7. 7

    Multicenter Longitudinal Observational Study Pharmaceuticals Alflutop in Russia (message 2) by A. M. Lila, E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova

    Published 2023-08-01

    Osteoarthritis (OA) is one of the most important medical and social problems due to the steady increase in morbidity and disability. Prevention, management of risk factors, and early treatment of OA are critical.Objective of the ISKRA study was to evaluate the efficacy of Alflutop in patients with O...

    Full description

    Get full text
    Article
  8. 8

    Osteoarthritis as an interdisciplinary problem: treatment algorithm for physicians and general practitioners by A. M. Lila, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova

    Published 2021-10-01

    Modern therapy of osteoarthritis (OA) consists of four sequential stages and includes non-pharmacological, pharmacological and surgical methods of treatment, and also assumes the possibility of collaborative management of the patient by doctors of different specialties, which allows to optimize the...

    Full description

    Get full text
    Article
  9. 9

    MULTIPLE BONE CYSTS CAUSED BY THE INTAKE OF LEFLUNOMIDE IN A FEMALE PATIENT WITH RHEUMATOID ARTHRITIS by L. I. Alekseeva, N. G. Kashevarova, E. A. Taskina, Ya. A. Sigidin

    Published 2018-11-01

    The paper describes a clinical case of adverse reaction (AR) to leflunomide (LEF) in a female patient with rheumatoid arthritis (RA). In 2007 to 2017, the female patient with a reliable diagnosis of RA took LEF (Arava) at a dose of 20 mg/day, which showed a good clinical effect. However, the patient...

    Full description

    Get full text
    Article
  10. 10

    Long-term multicenter observational study of the drug Alflutop in Russia: use in patients with knee osteoarthritis (report 4) by E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, A. M. Lila

    Published 2024-08-01

    Objective: to investigate the efficacy of Alflutop therapy in patients with knee osteoarthritis (OA) with or without concomitant diseases. Material and methods. The large-scale, multicenter prospective, open-label, observational, non-interventional ISKRA study (Study: Prescribing the drug Alflutop,...

    Full description

    Get full text
    Article
  11. 11

    Alflutop Russian longitudinal multicentre observational study: preliminary results (message 1) by A. M. Lila, L. I. Alekseeva, E. A. Taskina, N. G. Kashevarova

    Published 2023-04-01

    Evaluation of the effect of new drugs should be carried out in randomized controlled trials (RCTs), and observational studies (OSs) are carried out to confirm and refine the results obtained in RCTs, for example, to study the effectiveness of drugs in large groups of patients who were not included i...

    Full description

    Get full text
    Article
  12. 12

    Evaluation of the efficacy, tolerability, and safety of intra-articular hyaluronic acid in patients with knee osteoarthritis by S. G. Anikin, N. G. Kashevarova, T. A. Korotkova, E. P. Sharapova, L. I. Alekseeva

    Published 2017-09-01

    Objective: to evaluate the efficacy, tolerability, and safety of intra-articular hyaluronic acid (hyalurom) in patients with knee osteoarthritis (OA).Patients and methods. A 6-month prospective trial enrolled 20 women aged 45–75 years (61±7 years) with primary knee OA of Kellgren–Lawrence grades II...

    Full description

    Get full text
    Article
  13. 13

    Evaluation of the efficiency and safety of combined therapy with a symptomatic sustained-release drug and hyaluronic acid versus monotherapy with hyaluronic acid in patients with... by K. A. Berdyugin, I. V. Kadyntsev, O. V. Berdyugina, E. A. Taskina, N. G. Kashevarova

    Published 2020-09-01

    Osteoarthritis (OA) is the most common joint disease. Searching for new treatment methods and regimens for OA is relevant.Objective: to evaluate the efficiency and safety of therapy with a symptomatic sustained-release drug (Alflutop) in combination with intra-articular hyaluronic acid (HA) injectio...

    Full description

    Get full text
    Article
  14. 14

    Multimorbidity in osteoarthritis by E. A. Taskina, L. I. Alekseeva, N. G. Kashevarova, A. M. Lila, E. L. Nasonov

    Published 2022-07-01

    This review is focused on the issue of terminology in patients with multiple coexisting diseases in modern clinical practice. We articulate that multimorbidity is one of the leading problems in the field of public healthcare and that the treatment of these patients demands an integral approach deriv...

    Full description

    Get full text
    Article
  15. 15

    Comparison of continuous and intermittent treatment of patients with knee osteoarthritis with combined drug “Teraflex” by L I Alexeeva, N G Kashevarova, E P Sharapova, E M Saitseva, M. V. Severinova

    Published 2008-06-01

    Objective. To assess efficacy, safety and aftereffect duration of continuous and intermittent treatment of patients with knee osteoarthritis with “Teraflex”. Material and methods. 100 outpatients (2 groups 50 pts in each) mainly women (99 pts) with knee osteoarthritis 0I-III stage according to Kellg...

    Full description

    Get full text
    Article
  16. 16

    Assessment of efficacy and safety of “Chondroxid” gel in comparison with “Finalgel" in patients with knee osteoarthritis by L I Alexeeva, N G Kashevarova, E P Sharapova, E M Saitseva, M V Severinova

    Published 2008-06-01

    Objective. To assess efficacy, safety and aftereffect duration of 6-week local therapy of “Chondroxid” gel in comparison with ‘‘Finalgel” in patients with knee osteoarthritis. Material and methods. 60 outpatients (2 groups 30 pts in each) mainly women (59 pts) with knee osteoarthritis (II-III stage...

    Full description

    Get full text
    Article
  17. 17

    Efficacy of Chondroitin Sulfate in Patients with Knee and Hip Osteoarthritis by E. P. Sharapova, E. A. Taskina, N. G. Kashevarova, L. I. Alekseeva, A. M. Lila

    Published 2021-08-01

    Currently chondroitin sulfate (CS) is the most studied drug from the group of «chondroprotectors». The article shows the role of CS in the treatment of osteoarthritis (OA): mechanism of action, clinical efficacy and safety in patients with OA with comorbidity. Evidence for the effectiveness and safe...

    Full description

    Get full text
    Article
  18. 18

    The use of new aceclofenac dosage forms in patients with osteoarthrosis in real-life clinical practice by Lyudmila Ivanovna Alekseeva, E P Sharapova, N G Kashevarova, S G Anikin, T A Korotkova, E M Zaitseva

    Published 2014-03-01

    A new convenient dosage form of aceclofenac (sashet bags) has recently been launched on the Russian market. The powder in a single sashet bag weighs 3 g, which corresponds to 100 mg of the active ingredient per tablet. A prospective study (including evaluation of the effectiveness and safety of the...

    Full description

    Get full text
    Article
  19. 19

    Efficacy and safety of diacerein in patients with knee osteoarthritis by L. I. Alekseeva, N. G. Kashevarova, E. A. Taskina, E. P. Sharapova, S. G. Anikin, T. A. Korotkova, E. A. Strebkova

    Published 2017-09-01

    Diacerein (D) belongs to a class of symptomatic slow-acting agents, has an original mechanism of action, and is widely used as a diseasemodifying antirheumatic drug to treat osteoarthritis (OA) in Russia and many countries of the world. The ability of the drug to affect the main symptoms and progres...

    Full description

    Get full text
    Article
  20. 20

    Expression of genes related to glucose metabolism and joint destruction in the development of diabetes mellitus in patients with osteoarthritis by E. V. Chetina, E. P. Sharapova, N. G. Kashevarova, E. A. Taskina, G. A. Markova, L. I. Alekseeva, A. A. Lila

    Published 2019-03-01

    Many patients with osteoarthritis (OA) tend to have comorbidities. This tendency is more frequently observed to increase with age. One of the comorbidities is type 2 diabetes mellitus (T2DM). Due to the higher prevalence of coexistence of these two conditions, it has been suggested that T2DM-associa...

    Full description

    Get full text
    Article